LALCA 2023

Call for Abstracts

Call for Abstracts

The Scientific Program Committee for the IASLC 2023 Latin America Conference on Lung Cancer is inviting the submission of scientific abstracts. Please read the details below carefully before submitting an abstract.

Important Deadlines

Call for Abstract OpensAugust 24, 2022
Abstract Submission DeadlineOctober 14, 2022 (23:59 PDT)
Author Notifications of Acceptance November 16, 2022
Presenting Author Registration Deadline December 16, 2022 (23:59 PDT)
  • Oral Presentation
  • Poster Presentation
  • NOTE: Selecting Oral Presentation does not guarantee you will be assigned an oral abstract presentation upon acceptance; the final presentation type is determined by the Program Committee
  • Advanced NSCLC
  • Biology and Pathogenesis, Pathology
  • Early Stage NSCLC (Stage I – III)
  • Immunotherapy
  • Nursing & Allied Health & Patient Advocacy & Supportive Care
  • Prevention, Early Detection, Epidemiology and Tobacco Control
  • SCLC, Mesothelioma, Thymoma

Research work should be original and innovative. Work can be presented prior to the IASLC 2023 Latin America Conference on Lung Cancer meeting but MUST include new information/data. 

  • Abstract title: must not exceed 20 words in length (space excluded).
  • Abstracts body: must not exceed 400 words in length (not including title and authors). 
  • Tables/Image: 2 may be included, and each will count as 100 words.
  • Tables, images and graphs must be uploaded in GIF, JPEG, JPG or PNG format at 300 dpi and 100% size. Any higher resolution is acceptable. 
  • Abstract Structure: must be structured with the following headings: 
      • Background 
      • Methods 
      • Results 
      • Conclusion 
  • Please add the above headings (Background, Methods, Results, Conclusion) to each section of your abstract body. 
  • Language: abstracts will be accepted in English only. 
  • Fee: there is no fee for submitting an abstract. 
  • Submission numbers: there is no limit to the number of abstracts you may submit. 
  • Encore Submission: An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the abstract. Submitters are required to list any previously presented abstracts in the introduction of the abstract.
  • Encore Submission: An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the abstract. Submitters are required to list any previously presented abstracts in the introduction of the abstract. 
  • Trial in Progress: LALCA accepts the submissions of trials in progress. 
  • Publication: Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the Conference website. Most abstracts will be published and released prior to the meeting, except for embargoed abstracts which will be posted on the day of presentation. 

Definition: Plagiarism encompasses all of following:

  1. Direct: intentionally submitting another person’s words or ideas verbatim as one’s own;
  2. Self-plagiarism: submitting work that has been previously published or presented;
  3. Mosaic plagiarism: stringing together portions of text from other sources; and
  4. Lack of attribution: failing to appropriately identify and cite sources for language or ideas that are incorporated.

For more information see: Das N, Panjabi M. Plagiarism: Why is it such a big issue for medical writers? Perspect Clin Res. 2011;2(2):67–71. doi:10.4103/2229-3485.80370

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121267/ 

Screening: IASLC screens all abstracts using anti-plagiarism software. Abstracts identified as having high levels of plagiarized content will be evaluated by IASLC staff and appropriate actions taken.

Penalties for plagiarism may include: Rejection of abstract, and/or author(s) banned from making presentations at IASLC conferences.

Step 1. Title, Topic and Presentation Type 

  • The abstract title must not exceed 20 words in length.
  • Please enter the abstract title in Title Case
  • Please select the desired track for your abstract submission. The scientific program committee reserves the right to move the abstract to another track should it be seen as a better fit.
  • Please note your preferred presentation format. NOTE: Selecting Oral does not guarantee you will be assigned an oral abstract presentation upon acceptance; the final presentation type is determined by the Scientific Program Committee.

 Step 2. Authors 

  • Please enter the authors and affiliations of the abstract in title case.
  • There is no limit to the number of co-authors per abstract.
  • There is a limit of one presenting author per abstract.
  • If more than two authors are listed, please select who the presenting author is.
  • The presenting author of an accepted abstract must be registered by December 16, 2022.
  • Should a presenting author not be registered by the deadline the abstract may be removed from the program.

 Step 3. Abstract Text 

  • Do not include Title or Author data in the body of your abstract. Title and author should be entered in the steps above. 
  • Abstracts may be entered directly into the site or copied and pasted. 
  • Research work should be original and innovative. Work can be presented prior to the IASLC 2023 Latin America Conference on Lung Cancer, but MUST include new information/data.
  • Abstracts must not exceed 400 words in length (not including title and authors). 
  • A maximum of 2 Tables/Images may be included; each will count as 100 words. 
  • Tables, images and graphs must be uploaded in GIF, JPEG, JPG or PNG format at 300 dpi and 100% size. Any higher resolution is acceptable. 
  • Abstracts must be structured with the following headings: 
      • Background 
      • Methods 
      • Results 
      • Conclusion 
  • Please add the above headings (Background, Methods, Results, Conclusion) to each section of your abstract body. These headings will not count towards your word limit of 400. 

 Step 4. Preview & Submit 

  • Please proofread your submission prior to submitting. 
  • Once an abstract is submitted it cannot be deleted, modified or corrected in the system after submission. All submitted abstracts will be published exactly as submitted. 
  • Any abstracts in “Draft” status after the submission deadline has passed will not be considered for review. It is the abstract submitters responsibility to ensure that all abstracts you wish to be reviewed have been properly submitted. 
  • Should you need to withdraw a submitted abstract, please contact [email protected]. Please include the abstract number and abstract title in your email. 
  • Please carefully review the affiliation of all your co-authors as this is how it will appear in the Conference Program Book as well as on the Conference Website. 
  • You will be asked to review and agree to the abstract submission terms & conditions prior to submitting your abstract. Please read the information carefully. 

For inquires, please contact [email protected]. If your inquiry is regarding a particular draft or submission, please include the abstract number and title in your email.  

For any abstract related questions, please contact [email protected].

en_USEnglish